X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Pulmonary Arterial Hypertension Companies

This report lists the top Global Pulmonary Arterial Hypertension companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Pulmonary Arterial Hypertension industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Circulatory System Drugs Research PAH Industry Companies

Global Pulmonary Arterial Hypertension Top Companies

  1. Bayer AG

  2. Gilead Sciences, Inc.

  3. Johnson & Johnson (Actelion Pharmaceuticals, Ltd.)

  4. Pfizer, Inc.

  5. United Therapeutics Corporation

*Disclaimer: Top companies sorted in no particular order

Global Pulmonary Arterial Hypertension Market Major Players

Global Pulmonary Arterial Hypertension Market Concentration

Global Pulmonary Arterial Hypertension Market Concentration

Global Pulmonary Arterial Hypertension Company List

                          • Arena Pharmaceuticals

                          • Bayer AG

                          • Bristol-Myers Squibb Company

                          • Gilead Sciences, Inc.

                          • GlaxoSmithKline Plc

                          • Johnson & Johnson (Actelion Pharmaceuticals, Ltd.)

                          • Merck & Co. Inc.

                          • Novartis International AG

                          • Pfizer, Inc.

                          • United Therapeutics Corporation


                      Specific to Global Pulmonary Arterial Hypertension Market
                      Need More Details On Market Players And Competitors?
                      Download Sample

                      Pulmonary Arterial Hypertension (PAH) Market Report Snapshots

                      Pulmonary Arterial Hypertension Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)